176 related articles for article (PubMed ID: 34348871)
1. Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study.
Archangelidi O; Cullinan P; Simmonds NJ; Mentzakis E; Peckham D; Bilton D; Carr SB
J Cyst Fibros; 2022 Mar; 21(2):302-308. PubMed ID: 34348871
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.
Olesen HV; Drevinek P; Gulmans VA; Hatziagorou E; Jung A; Mei-Zahav M; Stojnic N; Thomas M; Zolin A;
J Cyst Fibros; 2020 Mar; 19(2):321-327. PubMed ID: 31680042
[TBL] [Abstract][Full Text] [Related]
3. Mediation of the total effect of cystic fibrosis-related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study.
Tanner KT; Daniel RM; Bilton D; Simmonds NJ; Sharples LD; Keogh RH
Diabet Med; 2022 Nov; 39(11):e14958. PubMed ID: 36075586
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors of paediatric cystic fibrosis-related diabetes.
Perrem L; Stanojevic S; Solomon M; Carpenter S; Ratjen F
J Cyst Fibros; 2019 Nov; 18(6):874-878. PubMed ID: 31072797
[TBL] [Abstract][Full Text] [Related]
5. Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis.
Caley LR; Zagoya C; Duckstein F; White H; Shimmin D; Jones AM; Barrett J; Whitehouse JL; Floto RA; Mainz JG; Peckham DG
J Cyst Fibros; 2023 Mar; 22(2):275-281. PubMed ID: 36710099
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
Kerem E; Viviani L; Zolin A; MacNeill S; Hatziagorou E; Ellemunter H; Drevinek P; Gulmans V; Krivec U; Olesen H;
Eur Respir J; 2014 Jan; 43(1):125-33. PubMed ID: 23598952
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Status and Risk of Cystic Fibrosis-Related Diabetes: A Retrospective Single Center Cohort Study.
Peng Y; Wu M; Alvarez JA; Tangpricha V
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836301
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of Pseudomonas and Aspergillus co-infected cystic fibrosis patients: A UK registry study.
Hughes DA; Archangelidi O; Coates M; Armstrong-James D; Elborn SJ; Carr SB; Davies JC
J Cyst Fibros; 2022 Jan; 21(1):129-135. PubMed ID: 33958279
[TBL] [Abstract][Full Text] [Related]
9. Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in France.
Rousset-Jablonski C; Dalon F; Reynaud Q; Lemonnier L; Dehillotte C; Jacoud F; Berard M; Viprey M; Van Ganse E; Durieu I; Belhassen M
Front Public Health; 2022; 10():1043691. PubMed ID: 36483264
[TBL] [Abstract][Full Text] [Related]
10. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes.
Sims EJ; Green MW; Mehta A
Diabetes Care; 2005 Jul; 28(7):1581-7. PubMed ID: 15983304
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and additional risk factors for cancer in adults with cystic fibrosis.
Knotts RM; Jin Z; Doyle JB; Keating C; DiMango E; Abrams JA
Cancer Causes Control; 2022 Dec; 33(12):1445-1451. PubMed ID: 36178608
[TBL] [Abstract][Full Text] [Related]
12. Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults.
Adler AI; Shine BS; Chamnan P; Haworth CS; Bilton D
Diabetes Care; 2008 Sep; 31(9):1789-94. PubMed ID: 18535191
[TBL] [Abstract][Full Text] [Related]
13. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
14. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.
Terliesner N; Vogel M; Steighardt A; Gausche R; Henn C; Hentschel J; Kapellen T; Klamt S; Gebhardt J; Kiess W; Prenzel F
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):815-821. PubMed ID: 28245190
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis-related diabetes in adults.
Cawood TJ; McKenna MJ; Gallagher CG; Smith D; Chung WY; Gibney J; O'Shea D
Ir Med J; 2006 Mar; 99(3):83-6. PubMed ID: 16700261
[TBL] [Abstract][Full Text] [Related]
16. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
[TBL] [Abstract][Full Text] [Related]
17. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis is associated with an increased risk of Barrett's esophagus.
Knotts RM; Solfisburg QS; Keating C; DiMango E; Lightdale CJ; Abrams JA
J Cyst Fibros; 2019 May; 18(3):425-429. PubMed ID: 30473189
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
20. The development of diabetes among Danish cystic fibrosis patients over the last two decades.
Knudsen KB; Mathiesen ER; Eriksen V; Skov M; Nielsen KG; Johannesen J; Pressler T
Pediatr Diabetes; 2015 May; 16(3):219-26. PubMed ID: 24891216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
